백서에서 실험적 치아이동시 치조골 흡수에 미치는 Bisphosphonate의 영향-생화학적 및 조직학적 관찰-
Effects of Bisphosphonate on Alveolar Bone Resorption during Experimental Tooth Movement in Rats -Biochemical ＆ Histological Observations-
최진휴, 강정채,
소속 상세정보
최진휴 ( ) - 순천향대학교
강정채 ( ) - 전남대학교 치과대학 교정학교실
KMID : 0361919990290010095
Abstract
백서에서 실험적 치아 이동시 bisphosphonate가 파골세포의 형성에 미치는 영향과 골 흡
수 억제기전을 규명하고 독성유무를 알아보고자 하였다. 체중 260-350g의 웅성 백서 87마리
를 정상군(장치비장착 +0.9％ NaCl), 대조군(장치장착 +0.9％ NaCl) 및 장치장착후
bisphosphonate 투여군(으로 분류하였다. 상악 좌측 제 1대구치를 근심으로 치아이동이 일
어나도록 50-70g의 교정력을 가하고, 교정장치 장착후 1일, 3일 및 7일째에 형성 acid
phosphatase와 lactate dehydrogenase(LDH)의 활성도를 측정하고, 또한 제 1대구치를 포함
한 상악골 일부에서 파골세포수 및 골흡수 정도를 조직학적으로 관찰하여 다음과 같은 성적
을 얻었다.
1, Acid phosphatase 활성도는 장치후 1일째와 3일째에 대조군과 bisphophonate 투여군에서
모두 정상군에 비해 2-3배 높았으나, 7일째에는 정상군과 유의한 차이를 보이지 않았다.
2. LDH활성도는 bisphosphonate 4㎎과 20㎎/㎏투여군에서 전 실험기간에 걸쳐 증가된 양
상을 보였으나 0.8㎎과 100㎎/㎏투여군에서는 유의한 차이를 나타내지 않았다.
3. 골흡수는 장치후 1일째에 대조군과 bisphosphonate 투여군에서 모두 관찰되지 않았으나,
3일 이후에 나타나 7일째까지 계속되었다, Bisphosphonate 4, 20 및 100㎎/㎏군에서의 골흡
수정도는 3일째에는 대조군에 비해 미약하였으나 7일째에는 대조군과 유사하게 나타났다.
4. 파골세포가 1일째에 대조군이나 bisphosphonate 투여군 모두에서 거의 관찰할 수 없었다.
3일째에 대조군에서는 파골세포가 다량 출현하였으나 bisphosphonate 투여군에서는 약물의
용량이 증가함에 따라 감소하여 나타났다.
이상의 결과로 실험적 치아이동시 파고세포의 형성억제가 bisphosphonate 에 의한 골흡수
억제기전이 아님을 알 수 있었고, bisphosphonate는 투여량이 증가에 따른 뚜렷한 세포독성
은 관찰되지 않았으며, 골흡수 억제효과를 지속시키기 위해서 약물이 반복적으로 투여되어
야 할 필요가 있음이 시사되었다.
#초록#
This study was performed to examine the effect of bisphosphonate, an inhibitor of
bone resorption, on the formation of osteoclast and bone resorption during experimental
tooth movement. Whether bisphosphonate has a cytotoxicity in high dose was also
examined. Eighty-seven male Sprague-Dawley rats. Weighing 260-350g, were classified
into normal (no appliance + 0.9％ NaCl), control (appliance + 0.9％ NaCl) and four
bisphosphonate-treated( appliance + 0.8㎎, 4㎎, 20㎎, or 100㎎/㎏) groups. The maxillary
left first molar was moved mesially with the tippping movement using 50-70g of force.
Bisphosphonate(etidronate disodium)was injected intraperitoneally with a dose of 0.8㎎, 4
㎎, 20㎎, or 100㎎/㎏ simultaneously with the application of the orthodontic force. They
were killed at day 1.3 or 7after the application of the orthodontic force. The activities of
serum acid phosphatase and lactate dehydrogenase (LDH) were assayed, and osteoclasts
and the degree of bone resorption were examined histologically.
The results obtained were as follows:
1. Acid phosphatase activities were significantly higher in the appliance groups, both
control and bisphosphonate-treated( 4, 20 and 100㎎/㎏) groups, at days 1and 3 than
these in normal. At day 1, bisphosphonate -treated(4, 20㎎/㎏) groups showed even
higher acid phosphatase than control. However, at day 7, no significant difference was
noted between the control and bisphosphonate-treated groups.
2. LDH activities in the 4, 20㎎/㎏ bisphosphonate-treated groups were increased during
the experimental periods examined, but there were no significant differences in the 0.8,
100㎎/㎏ bisphosphonate-treated groups.
3. There was no bone resorption at day 1, but severe bone resorption was observed at
days 3and 7 in the control. Bone resorption was reduced by bisphosphonate-treatment at
day 3. Bone resorption observed at day 7 was similar between the control and
bisphosphonate-treated groups.
4. Few osteoclasts were observed at the alveolar bone in the control and
biosphosphnate-treated groups at day 1. At day 3. numerous osteoclasts were shown in
the control, the degree of which was reduced in bisphosphonate-treated groups.
These results suggest that the inhibition of the osteoclast formation was not the
mechanism of bone resorption by the bisphosphonate-treatment during experimenal tooth
movement. There was no distinct cytotoxicity with a high dose of bisphosphonate. And
the drug should be administrated repeatedly to maintain the inhibitory effect of bone
resorption.
키워드
치아이동; Bisphosphonate; Acid phosphatase; LDH; 파골세포; Tooth movement; Bisphosphonate; Acid phosphatease; LDH; Osteoclast;
원문 및 링크아웃 정보
등재저널 정보